OTCMKTS:ORINY Orion Oyj (ORINY) Stock Price, News & Analysis → $25,000 into $109,616 in two months? (From WealthPress) (Ad) Free ORINY Stock Alerts $18.00 0.00 (0.00%) (As of 03/28/2024 ET) Add Compare Share Share Today's Range$18.00▼$18.0050-Day Range$18.00▼$23.6252-Week Range$18.00▼$24.40VolumeN/AAverage Volume273 shsMarket Capitalization$5.08 billionP/E Ratio21.43Dividend Yield2.06%Price TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartDividendEarningsHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartDividendEarningsHeadlinesShort Interest Get Orion Oyj alerts: Email Address Ad Crypto 101 MediaAltcoin FRENZY Alert…Bitcoin recently crossed the highest price in its 15-year history… Less than 2 years after one of the most vicious crypto market meltdowns we've ever seen! Bitcoin's BOOM also sent shockwaves through the altcoin market, with select coins seeing HUGE moves in a matter of days… Like Fetch.ai, that gained over 350% in just the last 30 days… Click here now to register for the event (FOR FREE!) About Orion Oyj Stock (OTCMKTS:ORINY)Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, other European countries, North America, and internationally. The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; Precedex, dexdor and Precedex for human use; Burana for inflammatory pain; Divina series for menopausal symptoms; Trexan for rheumatoid arthritis and cancer; Stalevo, entacapone, and Comtess/Comtan for Parkinson's disease; Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure; as well as Fareston for breast cancer. It also offers Salmeterol/fluticasone Easyhaler; Budesonide/formoterol Easyhaler; Formoterol Easyhaler; Budesonide Easyhaler; Beclomet Easyhaler; and Buventol Easyhaler drugs for the treatment of asthma and chronic obstructive pulmonary disease. In addition, the company provides veterinary drugs comprising Bonqat, Clevor, Domosedan, Domitor, Antisedan, Dexdomitor, Domosedan Gel, Sileo, and Tessie; APIs for generic compounds and proprietary products, as well as provides fermion and contract manufacturing services; and markets and sells veterinary drugs manufactured by other international companies. Further, the company has partnership with Propeller Health to connect the Easyhaler(R) product portfolio; and a research collaboration and license agreement with Amneal Pharmaceuticals, Inc. to commercialize Amneal's generic products. Orion Oyj was founded in 1917 and is headquartered in Espoo, Finland.Read More ORINY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ORINY Stock News HeadlinesMarch 20, 2024 | msn.comOrion Oyj goes ex dividend tomorrowMarch 19, 2024 | seekingalpha.comORN Orion Group Holdings, Inc.March 28, 2024 | DTI (Ad)Warning: this could blow your mindBuckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…March 4, 2024 | finance.yahoo.comOrion Corporation: Managers’ transactions – Juhani KankaanpääFebruary 26, 2024 | realmoney.thestreet.comOrion Oyj just downgraded at Jefferies, here's whyFebruary 22, 2024 | finance.yahoo.comOrion and Save the Children Finland announce cooperation to promote well-being of children in Finland and globallyFebruary 21, 2024 | investing.comOrion Oyj B (ORNBV)February 19, 2024 | finance.yahoo.comOrion to investigate the possible outsourcing of its pharmaceutical production in Kuopio, FinlandMarch 28, 2024 | DTI (Ad)Buy Friday, Sell Monday, No Exceptions Every week traders grind it out Monday through Friday… But neglect trading Friday to Monday… Or… “over the weekend” As one professional trader explains, trading over the weekend is one of the most forgiving strategies you can use today. It allows him to sidestep a lot of the midweek volatility. Yet, gives him the opportunity to target some of the markets biggest stock moves. Just recently, he posted a trade on Nordstrom… The trade was published at 3pm on a Friday afternoon and by Monday morning the trade more than doubled.February 13, 2024 | finance.yahoo.comOrion Group Financial Statement Release January–December 2023February 7, 2024 | finance.yahoo.com119,021 Orion Corporation A shares converted into B sharesJanuary 29, 2024 | finance.yahoo.comOrion Corporation and Newel Health enter into licensing agreement for a digital therapeutic (DTx) ODD-403 (“Rohkea”) in painJanuary 29, 2024 | finance.yahoo.comOrion publishes Financial Statement Release for 2023 and holds a webcast on 13 February 2024January 27, 2024 | finance.yahoo.comAdditional ODM-208/MK-5684 Phase II data presented at ASCO-GU 2024January 11, 2024 | finance.yahoo.comInsurance portfolio of Orion Pension Fund’s B fund transferred to an external pension insurance company – the transfer has approximately EUR 31 million positive impact on Orion’s result in 2023January 11, 2024 | finance.yahoo.comRecommendation by the Orion Nomination Committee on the proposals to be submitted to the 2024 Annual General MeetingJanuary 8, 2024 | msn.comOrion collaborates with Glykos to develop next-generation ADCsJanuary 8, 2024 | finance.yahoo.comOrion and Glykos announce research collaboration and licensing agreement to develop next-generation ADCsJanuary 8, 2024 | finance.yahoo.comOrion Corporation: Managers’ transactions – Ari LehtorantaJanuary 6, 2024 | morningstar.comOrion Oyj ADR ORINYJanuary 5, 2024 | finance.yahoo.comOrion and MSD Announce Initiation of Two Phase 3 Trials Evaluating ODM-208/MK5684 in Certain Patients with Metastatic Castration-Resistant Prostate CancerDecember 27, 2023 | finance.yahoo.comNEJM Evidence publishes results from Phase I/IIa CYPIDES trial with ODM-208December 4, 2023 | finance.yahoo.com87 000 Orion Corporation A shares converted into B sharesNovember 21, 2023 | finance.yahoo.comPhase 3 Clinical Trials with ODM-208 (MK-5684) posted to ClinicalTrials.gov databaseNovember 20, 2023 | finance.yahoo.comOrion Animal Health receives FDA approval for Bonqat® (pregabalin oral solution)November 15, 2023 | finance.yahoo.comOrion Research Foundation grants EUR 1,112,000 for research in 2024November 10, 2023 | morningstar.comOrion Oyj Class B ORNBVSee More Headlines Receive ORINY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Orion Oyj and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/13/2024Today3/28/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Private households Sub-IndustryN/A Current SymbolOTCMKTS:ORINY Previous SymbolNASDAQ:ORINY CUSIPN/A CIKN/A Webwww.orion.fi Phone358 10 4261FaxN/AEmployees3,527Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.84 Trailing P/E Ratio21.43 Forward P/E Ratio20.22 P/E GrowthN/ANet Income$234.62 million Net Margins18.21% Pretax Margin19.55% Return on Equity27.75% Return on Assets16.32% Debt Debt-to-Equity Ratio0.21 Current Ratio3.10 Quick Ratio1.59 Sales & Book Value Annual Sales$1.29 billion Price / Sales3.95 Cash Flow$1.48 per share Price / Cash Flow12.15 Book Value$3.39 per share Price / Book5.31Miscellaneous Outstanding Shares282,270,000Free FloatN/AMarket Cap$5.08 billion OptionableNot Optionable Beta0.25 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesDr. Liisa Hurme (Age 57)President, CEO & Chairman of Executive Management Board Comp: $842.84kMr. Jari Karlson M.Sc. (Age 63)M.Sc. (Econ.), CFO & Member of the Executive Management Board Mr. Olli Huotari Ll.M. (Age 58)Senior VP of Corporate Functions, General Counsel, Secretary & Member of Executive Management Board Ms. Satu Ahomäki M.Sc. (Age 58)M.Sc. (Econ.), Senior VP of Generics and Consumer Health Business Division & Member of the Exe. Mgmt. Board Ms. Virve Laitinen M.Sc. (Tech.) (Age 52)MBA, Sr. VP of Corporate Strategy and Program Mgmt. Grp. Level Function & Member of the Exe. Mgmt. Board Prof. Outi Vaarala M.D. (Age 62)Ph.D., Sr. VP of Innovative Medicines, Sr. VP of R&D and Member of the Exe. Mgmt. Board Mr. Juhani KankaanpaaSenior VP of Global Operations & Member of Executive Management BoardMr. Niclas Lindstedt EMBAM.Sc., Senior VP of Animal Health Business Division & Member of the Exe. Mgmt. BoardMr. Hao Pan M.Sc. (Age 53)Senior VP of the Branded Products Business Division & Member of the Exe. Mgmt. Board Ms. Julia Irene Macharey (Age 47)Senior Vice President of People & Culture and Member of Management Board More ExecutivesKey CompetitorsAspen PharmacareOTCMKTS:APNHYZealand Pharma A/SOTCMKTS:ZLDPFAurora CannabisOTCMKTS:ACBFFGN Store Nord A/SOTCMKTS:GNNDYUDG HealthcareOTCMKTS:UDHCFView All Competitors ORINY Stock Analysis - Frequently Asked Questions Should I buy or sell Orion Oyj stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Orion Oyj in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ORINY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ORINY, but not buy additional shares or sell existing shares. View ORINY analyst ratings or view top-rated stocks. How have ORINY shares performed in 2024? Orion Oyj's stock was trading at $20.70 at the start of the year. Since then, ORINY stock has decreased by 13.0% and is now trading at $18.00. View the best growth stocks for 2024 here. Are investors shorting Orion Oyj? Orion Oyj saw a decline in short interest in the month of March. As of March 15th, there was short interest totaling 100 shares, a decline of 50.0% from the February 29th total of 200 shares. Based on an average daily volume of 200 shares, the short-interest ratio is presently 0.5 days. View Orion Oyj's Short Interest. How were Orion Oyj's earnings last quarter? Orion Oyj (OTCMKTS:ORINY) posted its quarterly earnings results on Tuesday, February, 13th. The company reported $0.29 earnings per share (EPS) for the quarter. The business had revenue of $345.76 million for the quarter. Orion Oyj had a trailing twelve-month return on equity of 27.75% and a net margin of 18.21%. Is Orion Oyj a good dividend stock? Orion Oyj (OTCMKTS:ORINY) pays an annual dividend of $0.37 per share and currently has a dividend yield of 2.06%. The dividend payout ratio is 44.05%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, ORINY will have a dividend payout ratio of 36.27% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for ORINY. How do I buy shares of Orion Oyj? Shares of ORINY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:ORINY) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaFed launches fourth dollar overhaulStansberry ResearchBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the MarketsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryOnly a fool would buy Nvidia today… Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orion Oyj Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.